Medical Developments Company Top Insiders

MDDVF Stock  USD 0.30  0.01  3.23%   
Medical Developments employs about 9 people. The company is managed by 9 executives with a total tenure of roughly 21 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Medical Developments' management performance can provide insight into the company performance.
Wayne Pearce  Insider
Head Production
Brent MacGregor  Insider
Chief Officer
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Developments International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Medical Developments Management Team Effectiveness

The company has return on total asset (ROA) of (0.0787) % which means that it has lost $0.0787 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1976) %, meaning that it generated substantial loss on money invested by shareholders. Medical Developments' management efficiency ratios could be used to measure how well Medical Developments manages its routine affairs as well as how well it operates its assets and liabilities.

Medical Developments Workforce Comparison

Medical Developments International is regarded third in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 316. Medical Developments holds roughly 9.0 in number of employees claiming about 2.85% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (0.55) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.54) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.54.

Medical Developments Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Medical Developments Price Series Summation is a cross summation of Medical Developments price series and its benchmark/peer.

Medical Developments Notable Stakeholders

A Medical Developments stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medical Developments often face trade-offs trying to please all of them. Medical Developments' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medical Developments' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Medical Developments Management Performance

The success or failure of an entity such as Medical Developments often depends on how effective the management is. Medical Developments management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medical management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medical management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Medical Developments International Limited manufactures and distributes pharmaceutical and veterinary products, and medical devices. The company was incorporated in 2003 and is headquartered in Scoresby, Australia. Medical Developments operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 68 people.

Medical Developments Workforce Analysis

Traditionally, organizations such as Medical Developments use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medical Developments within its industry.

Medical Developments Manpower Efficiency

Return on Medical Developments Manpower

Revenue Per Employee2.5M
Revenue Per Executive2.5M
Net Loss Per Employee1.4M
Net Loss Per Executive1.4M

Complementary Tools for Medical Pink Sheet analysis

When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Transaction History
View history of all your transactions and understand their impact on performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios